Visit EmeritusDX at CAP (Booth 114) & ACG (Booth 1635) | Explore Our Solutions
Client Services:800-959-2846|Billing:949-374-5019
STIDX™
ABOUT OUR TEST
STIDX™ is a urine based test designed to identify pathogens commonly associated with sexually transmitted infections. Utilizing PCR technology, we are able to detect the presence of 8 pathogens. Our turnaround time for the test is 24 hours.
WHAT DOES OUR STI PANEL COVER?
Our comprehensive test was developed to deliver results for even the most difficult UTIs to diagnose and treat. By targeting pathogens, you can feel confident in getting to the right answer with our STI Panel.
OUR REQUISITION
Review our requisition for a complete list of the Urology services that we provide.
Urology Services
Prostate Biopsies
Prostate biopsies are performed when results from initial tests, like a prostate-specific antigen (PSA) blood test or digital rectal exam, indicate the possibility of prostate cancer. A range of tissue samples are extracted with a needle from the prostate gland and are analyzed under a microscope using a Hematoxylin & Eosin stain, and in
Prostate biopsies are performed when results from initial tests, like a prostate-specific antigen (PSA) blood test or digital rectal exam, indicate the possibility of prostate cancer. A range of tissue samples are extracted with a needle from the prostate gland and are analyzed under a microscope using a Hematoxylin & Eosin stain, and in some cases, immunohistochemical stains to identify cancerous cell abnormalities. If cancer is present, it can be localized to the exact region of the prostate from the location of the tissue extraction.
Bladder & Urovysion FISH
This FISH test is designed to detect aneuploidy for chromosomes 3, 7, and 17 and loss of the 9p21 locus, via fluorescence in situ hybridization (FISH) in urine specimens from persons with hematuria suspected of having bladder cancer. Results are intended for use in conjunction with, and not in lieu of, current standard diagnostic procedur
This FISH test is designed to detect aneuploidy for chromosomes 3, 7, and 17 and loss of the 9p21 locus, via fluorescence in situ hybridization (FISH) in urine specimens from persons with hematuria suspected of having bladder cancer. Results are intended for use in conjunction with, and not in lieu of, current standard diagnostic procedures (urine cytology) as an aid for initial diagnosis of bladder carcinoma in patients with hematuria and subsequent monitoring for tumor recurrence in patients previously diagnosed with bladder cancer.
Urine Cytology
Urine Cytology
Urine Cytology
Urine cytology is a test to look for abnormal cells in your urine. It's used with other tests and procedures to diagnose urinary tract cancers, most often bladder cancer. A urine cytology test may be initiated if blood is detected in the urine (hematuria). For people who've been diagnosed with bladder cancer and have undergone treatment, a urine cytology test can help detect a recurrence
Bladder17™
Urine Cytology
Urine Cytology
Uro17™ is a urine-based biomarker test to detect bladder cancer in people with symptoms of bladder cancer. It is also used to monitor for recurrence during treatment follow up. The innovative aspect is that it is a non-invasive diagnostic tool that detects bladder cancer based on the novel biomarker keratin 17 (K17). It can help stratify
Uro17™ is a urine-based biomarker test to detect bladder cancer in people with symptoms of bladder cancer. It is also used to monitor for recurrence during treatment follow up. The innovative aspect is that it is a non-invasive diagnostic tool that detects bladder cancer based on the novel biomarker keratin 17 (K17). It can help stratify patients with suspected bladder cancer and prioritize them for further secondary care investigations